Also visit: ThrillOf
 

FDA urged to halt review on prasugrel over safety issues external link

Pharma Times | Thu, Jun 4

John Hayes of Eli Lilly Research Laboratories, remarked that "the additional chronic osteoarthritis pain and chronic low back pain data were not available ...

and more »

[Read original...]

Try These Related Topics

 
 
 

Do you publish a blog? If so, consider joining the Boxxet Network and see your great content showcased and rewarded! Learn more...

©2009 Boxxet, Inc. | Contact | Privacy Policy | Terms of Service
Page updated Fri, Jan 29.